SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending following the introduction of a new high-efficiency solar cell, which community members view as a strategic move to address supply chain constraints. While some traders express optimism regarding the company's long-term growth and its acquisition of Iridium, sentiment remains mixed as others voice concerns over share dilution and skepticism regarding the development timeline for the Neutron rocket.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending as traders analyze the company's recent earnings beat and strong backlog, with many viewing current price levels as an attractive buying opportunity despite recent volatility. The community remains largely bullish on the company's role in the AI data center infrastructure buildout, though some express frustration over insider selling and previous share offerings.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as the community anticipates the upcoming Phase 3 eGFR data readout, which many investors view as a pivotal binary event that could trigger a significant re-rating of the stock. Traders are expressing high conviction in the drug's potential, frequently citing strong short interest and institutional ownership as catalysts for a possible breakout.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is experiencing significant selling pressure amid concerns over ongoing insider share sales and high short interest, with traders debating whether the stock's current decline represents a sustained bearish trend or an accumulation opportunity tied to AI infrastructure demand.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders speculate on positive guidance updates and upcoming clinical catalysts, particularly trial data for non-small cell lung cancer (NSCLC). Community discussion reflects significant optimism regarding the company's solid tumor platform and potential institutional accumulation, despite some investor frustration over the timing of management's forward-looking guidance.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The index is trending amid investor uncertainty surrounding a potential artificial intelligence development slowdown, while rising Treasury yields and oil prices drive significant volatility. Sentiment remains polarized as traders debate the likelihood of an interest rate hike during the upcoming central bank policy meeting, leading to rapid intraday price swings.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending as investors discuss the official completion of the Onyx acquisition of Chain Technology and Services, with many community members debating whether this integration of real-world payments infrastructure justifies long-term bullishness or if the asset remains a target for speculative pump-and-dump activity.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending as investors show strong interest in its upcoming merger with Agility Robotics, a company positioned as a pure-play leader in humanoid robotics backed by high-profile tech giants. The discussion is driven by excitement over potential adoption in logistics and manufacturing, though some traders urge caution regarding the inherent risks of pre-merger SPACs and valuations.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon is experiencing significant volatility as traders debate the impact of heavy insider selling by company executives and the stock's high valuation relative to its software business model. While some remain bullish on the company's long-term growth in public safety technology, others are actively shorting the stock, viewing recent price movements as an unsustainable "Trump pump" or prone to manipulation.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

Corsair Gaming is receiving attention as traders monitor its recent share price appreciation, with sentiment heavily focused on potential short squeeze dynamics driven by a significant short interest. Supporters point to strong margins, product demand in sim racing and peripherals, and a perceived turnaround as evidence that the company is undervalued compared to peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The price move appears tied to ongoing investor focus on federal rescheduling developments, as traders continue to monitor the status of legal challenges regarding the Schedule III order.

Tilray Brands, Inc. (TLRY) Gains As Market Dips: What You Should Know

Tilray Brands, Inc. (TLRY) closed at $4.14 in the latest trading session, marking a +2.99% move from the prior day.

Tilray Trades Below $5 With Record Fiscal Revenue on the Books. What's Holding the Stock Back?

Key PointsShares of Tilray Brands have fallen roughly 50% so far in 2026...

TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?

Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.

Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $4.3, denoting a -4.44% move from the preceding trading day.

Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands?

Key PointsTilray is seeing more revenue from beverages than from cannabis...

Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors

Tilray Brands, Inc. (TLRY) concluded the recent trading session at $4.5, signifying a -1.53% move from its prior day's close.

Tilray Brands, Inc. (TLRY) Dips More Than Broader Market: What You Should Know

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $4.72, denoting a -2.48% move from the preceding trading day.

Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?

Canopy Growth's cannabis business is showing signs of a turnaround, with revenue growth, improving margins and a narrower EBITDA loss fueling its rally.

Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $4.48, denoting a -4.07% move from the preceding trading day.

Should You Buy ACB Stock Amid Curaleaf's Hostile Takeover Attempt?

Aurora Cannabis faces a potential Curaleaf takeover at a 45% premium, but investors must weigh the offer against ACB's standalone prospects.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

PSKY, ORCL, TLRY Stocks Hit 52-Week Lows Today: What's Driving The Selloff? 

Equity

Bearish Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Earnings

Fundamentals

Info

TLRY News